dalteparin has been researched along with Superior Vena Cava Obstruction in 3 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Concha-Garzon, M | 1 |
Sotomayor-Lopez, E | 1 |
Solano-Lopez, G | 1 |
Fraga, J | 1 |
De Argila, D | 1 |
Giuliani, J | 1 |
Martelli, S | 1 |
Piacentini, P | 1 |
Bonetti, A | 1 |
Fasano, R | 1 |
Kent, P | 1 |
Valentino, L | 1 |
1 review available for dalteparin and Superior Vena Cava Obstruction
Article | Year |
---|---|
Superior vena cava thrombus treated with low-dose, peripherally administered recombinant tissue plasminogen activator in a child: case report and review of the literature.
Topics: Anti-Bacterial Agents; Anticoagulants; Antineoplastic Combined Chemotherapy Protocols; Bacteremia; C | 2005 |
2 other studies available for dalteparin and Superior Vena Cava Obstruction
Article | Year |
---|---|
Bullous hemorrhagic dermatosis distant from the site of heparin injection.
Topics: Enoxaparin; Female; Fibrinolytic Agents; Hemorrhage; Humans; Injections; Skin Diseases, Vesiculobull | 2014 |
Thromboembolic disease in advanced colorectal cancer treated with chemotherapy and bevacizumab: a case of real "pan-thrombosis".
Topics: Angiogenesis Inhibitors; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Pro | 2015 |